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Abstract
Hair loss may accompany several endocrine disorders, including hypopituitarism, hypothyreosis, hyperthyreosis, hypoparathyroidism,
diabetes mellitus, growth hormone deficiency, hyperprolactinaemia, polycystic ovary syndrome, SAHA syndrome, congenital adrenal
hyperplasia, Cushing syndrome, or virilising tumours. Most patients with endocrine disorders present with diffuse non-scarring alopecia,
such as anagen effluvium, telogen effluvium or androgenetic alopecia. Focal non-scarring alopecia, such as alopecia areata coexisting with
autoimmune thyroiditis, is less frequent and scarring alopecia is a rare finding in patients with endocrine abnormalities. In some cases an
endocrine disorder may be suspected based on dermatological findings during hair loss evaluation. Classic methods of hair evaluation
include hair weighing, pull test, wash test, the trichogram, and histopathological examination. Newly developed non-invasive diagnostic
techniques include the phototrichogram, trichoscan, trichoscopy, and reflectance confocal microscopy.
(Pol J Endocrinol 2010; 61 (4): 406–411)
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Streszczenie
Łysienie może towarzyszyć wielu chorobom endokrynnym (lub gruczołów dokrewnych) między innymi niedoczynności przysadki, nie-
doczynności i nadczynności tarczycy, niedoczynności przytarczyc, cukrzycy, niedoborowi hormonu wzrostu, hiperprolaktynemii, zespo-
łowi policystycznych jajników, zespołowi SAHA, zespołowi Cushinga, wrodzonemu przerostowi nadnerczy i guzom wirylizującym.
U większości pacjentów z endokrynopatiami obserwuje się rozlane łysienie niebliznowaciejące: anangenowe, telogenowe lub łysienie
androgenowe. Rzadziej spotyka się ogniskowe, niebliznowaciejące łysienie plackowate występujące u pacjentów z zapaleniami tarczycy
oraz łysienie bliznowaciejące. W niektórych przypadkach wyniki badania dermatologicznego pacjentów z łysieniem mogą nasunąć po-
dejrzenie choroby endokrynologicznej. Klasycznymi metodami badania chorób skóry owłosionej głowy jest ważenie włosów, test pocią-
gania, test mycia, trichogram i badanie histopatologiczne. Nowymi, nieinwazyjnymi metodami diagnostycznymi są: fototrichogram, tri-
choskan, trichoskopia i obrazowanie włosów i skóry owłosionej głowy metodą refleksyjnej konfokalnej mikroskopii skaningowej in vivo.
(Endokrynol Pol 2010; 61 (4): 406–411)
Słowa kluczowe: łysienie, łysienie telogenowe, łysienie androgenowe, trichogram, trichoskopia
Introduction
Hair loss may accompany several endocrine disorders,
including hypopituitarism, hypothyreosis, hyperthyre-
osis, hypoparathyroidism, diabetes mellitus, growth
hormone deficiency, hyperprolactinaemia, polycystic ova-
ry syndrome, SAHA syndrome, congenital adrenal hyper-
plasia, Cushing syndrome, or virilising tumours [1, 2]. In
some cases, an endocrine disorder may be suspected based
on hair and scalp evaluation.
Androgenic alopecia (AGA) is a common disorder
affecting both men and women. Although this is an
androgen-dependent disease, it most commonly affects
persons with normal serum levels of androgens [3]. The
pathogenesis of androgenic alopecia is known in more
detail in male androgenic alopecia as compared to fe-
male androgenic alopecia. In males, the increased ex-
pression of 5 a-reductase and dihydrotestosterone
(DHT) in the perifollicular area drives progressive hair
follicle miniaturization and symptoms of hair loss [4].
The role of DHT in female androgenic alopecia is not
clear. Some authors (Olsen), indicate that the pathogen-
esis of hair loss in “androgen-dependent” areas in fe-
males is multifactoral and, thus, the term “female pat-
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tern hair loss” should be used for decreased hair densi-
ty in the central scalp, especially in females who show
no abnormalities in serum concentrations of androgens.
Telogen effluvium is hair loss that results from in-
creased premature entering of hair into the telogen
phase and, in consequence, increased shedding of telo-
gen hairs. This is an acute or chronic diffuse hair loss
which may be caused by a variety of triggers. The most
common endocrine triggers of telogen effluvium in-
clude hypothyreosis, hyperthyreosis, hyperprolacti-
naemia, and polycystic ovary syndrome [1, 2, 5, 6].
Alopecia areata is characterized most commonly by
acute focal hair loss, which may progress to alopecia
totalis. Variants with diffuse or ophiatic hair loss and
slow disease progression are not uncommon. About 25%
of patients with alopecia areata demonstrate features
of autoimmune thyroiditis [7]
Classic methods of hair evaluation include hair
weighing, pull test, wash test, the trichogram, and his-
topathological examination. Newly developed non-in-
vasive diagnostic techniques include the phototri-
chogram, trichoscan, trichoscopy, and reflectance con-
focal microscopy [3]. This review summarizes current
hair and scalp diagnostic and monitoring techniques
which may be useful in evaluating and monitoring hair
loss in patients with endocrine disorders.
Wash test
The wash test is an uncomplicated method, developed
to distinguish between androgenic alopecia and telo-
gen effluvium. The method was based on the notion
that in telogen effluvium hairs will be shed during hair
washing in increased numbers, while in androgenic
alopecia there would be no active shedding. Despite an
attempt to reactivate this method in recent years, it
should be considered a historical and inadequate meth-
od in modern dermatology as it lacks specificity and
sensitivity [8].
Hair pull test
The hair pull test is a simple, in office test to estimate
the activity of hair loss. In a patient who did not wash
their hair for over 24 hours before examination, about
40–60 hairs are grasped between the index finger, mid-
dle finger, and the thumb. The hairs are then pulled
gently but with firm pressure as fingers slide along the
hair shaft. The test is positive, when 6 or more hairs
remain in the hands of the examiner [9]. This proce-
dure may be repeated in three scalp areas: frontal, oc-
cipital, right or left parietal. Hairs which remain in the
fingers of the examiner are telogen hairs, and their num-
ber corresponds to the percentage of telogen hairs on
the scalp. Test result is positive in telogen effluvium,
but is not specific for this disease. It can also be positive
in the active phase of alopecia areata or anagen alope-
cia. The test is difficult to perform in patients with short
hair. The pull test is a very approximate method, diffi-
cult to standardize, with low specificity and sensitivity,
but it might be helpful as a secondary procedure to as-
sess activity of hair loss.
Hair weighing
Hair weighing is a diagnostic tool for hair growth eval-
uation in clinical studies. It is used to analyze the effect
of topically or systematically applied drugs or cosmetic
molecules. A 1.34 cm2 area in the fronto-partial region
is shaved. The site is permanently marked by a tattoo.
After a treatment-free period of 4–24 months, hairs are
clipped and collected. The area is then shaved again.
The therapeutic agent is applied and hair is allowed to
grow for the same time period as in the previous phase of
the study. Again, hairs are clipped and collected. Then the
hair collected from both sampling periods is degreased
and weighed. Drugs and cosmetics are considered to have
good efficacy when the weight of the second sample is
more than the weight of the first sample [10].
Unit area trichogram
The unit area trichogram is a semi-invasive method for
scalp hair, which estimates three main growth parame-
ters: hair follicle density, proportion of anagen/telogen
fibres, and hair shaft diameter. It is based on plucking
hair from a defined area (usually 60 mm2). The hairs are
assessed clinically and microscopically. The unit area
trichogram may be used for follow-up of scalp hair
changes in clinical studies, for observing hair growth
cycling, and for monitoring topical or systemic drug and
cosmetic effects. This test has the disadvantage of be-
ing dependent on correct sampling [11, 12]. For this rea-
son, the classic trichogram (as describe below) is more
useful for clinical practice.
Trichogram
The trichogram is a semi-invasive microscopic method,
which is most commonly used to evaluate hair loss in clin-
ical practice in Europe. It allows the analysis of the pro-
portion of hair in different phases of the hair cycle [12].
The patient should not wash their hair for three days
prior to the examination. About 100 hairs are plucked
from the scalp using rubber-armed forceps. The hairs
are removed with one, quick, forceful pull perpendicu-
lar to the scalp and always along the direction of hair
growth. In most cases two sites are investigated. The
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first site is 2 cm off the frontal line and 2 cm off the
midline. The second site is in the occipital region, 2 cm
lateral from the protuberans occipitalis. In alopecia ar-
eata, the first site would be in close proximity to an
alopecia patch and the second in the contralateral, clin-
ically unaffected side. There is a variant of performing
a trichogram, in which hairs are plucked from four sites
(frontal, occipital, right and left parietal). The hair roots
are evaluated under light microscopy to determine the
number of hairs in the different phases of the hair cy-
cle. The results are given as a percentage of the total
number of hairs being evaluated. Normal values are:
anagen hairs 66–96%, catagen hairs 0–6%, telogen hairs
2–18%, and dysplastic/ dystrophic hairs 0–18% [13]
The trichogram is most useful in the diagnosis of
acute telogen effluvium. In such cases the percentage
of telogen hairs is significantly increased and can be
double the upper limit [2, 13]. The increased percent-
age of dystrophic hair and slightly increased percent-
age of telogen hairs accompanied by features of hair
miniaturization is noticed in androgenic alopecia, but
the results of the trichogram are not clear-cut for the
diagnosis of this disease [14]. An additional barrier in
diagnosing androgenic alopecia with this method is the
fact that technically vellus hairs, a hallmark of andro-
genic alopecia, are not plucked for investigation because
they are too short to be plucked together with the bun-
dle of terminal hairs.
The trichogram may also be applied for treatment
monitoring, in particular in patients with telogen efflu-
vium [13, 15]
Phototrichogram
The phototrichogram is a non-invasive method which
is based on sequential macro photographs of a selected
scalp area. This method is based on the notion that
anagen hairs grow at a rate of about 1 mm every 3 days,
while in the same time catagen hairs will show only
moderate elongation and telogen hairs will not grow at
all [16, 17] For the evaluation, 1–3 areas of about 1 cm2
each are shaved. This area is then photographed. After
3 days a second photograph is taken and the propor-
tion of growing (anagen) hairs is evaluated.
As in the classic trichogram, a significantly increased
proportion of telogen hairs is indicative of acute telo-
gen effluvium [13, 18].
This method is not widely used because of its limit-
ed value in broad hair diagnostics, possible inaccuracy
in sampling, and because patients with hair loss are re-
luctant to have their hair shaved.
Trichoscan
Trichoscan is based on the same theoretical foundation
as the phototrichogram. [19, 20]. There are, however,
two major differences. The technique is automated,
based on software which was developed for image eval-
uation, and dermoscopy photographs are used instead
of conventional photography. To enhance hair visibili-
ty, the inspected area is dyed with a colouring solution
(e.g. Goldwell top chic, black 2N, Darmstadt, Germa-
ny) [13].
This method has similar indications as the classic tri-
chogram. It has the advantage of being automated, but
the disadvantage of not being sensitive to hair shaft
abnormalities, thin regrowing hairs in telogen effluvi-
um, or merely debris from the hair dye [14].
Trichoscopy
Trichoscopy is a method of hair image analysis based
on dermoscopy or videodermoscopy of the hair and
scalp [21, 22]. It allows the visualization of hair and hair
follicle ostia at high magnification and the measurement
of relevant trichologic structures. The usual working
magnifications are 20- and 70-times; however, a hand-
held dermoscope, which gives 10-times magnification,
may be sufficient in many clinical situations.
A regular trichoscopy screening includes evaluation
of the hair and scalp in the frontal, occipital, and both
parietal areas. In selected cases other locations are cho-
sen for trichoscopy. These include eyebrows, eyelash-
es, or body hairs in other areas.
Trichoscopy allows the distinction between normal
terminal hairs and vellus (or vellus-like) hairs, which
by definition are 0.03 mm or less in thickness. The meth-
od enables visualization of micro-exclamation hairs
which may be 1–2 mm or less in length and structural
hair shaft abnormalities. The number of hairs in one
pilosebaceous unit may be assessed [23]
It may be seen whether hair follicles are normal,
empty, fibrotic (“white dots”), filled with hyperkeratot-
ic plugs (“yellow dots”), or contain destroyed hair re-
mains (“black dots”) [24]. Cutaneous miscovasculature
and its abnormalities may be appreciated in scalp skin.
In androgenic alopecia, trichoscopy allows visual-
ization of abnormalities, which are known from re-
search, performed with invasive and semi-invasive tech-
niques. According to criteria developed by Rakowska
et al., female androgenic alopecia may be differentiat-
ed from chronic telogen effluvium based on the follow-
ing trichoscopy criteria [25]. The major criteria are the
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ratio of: 1. more than 4 yellow dots in 4 images (70-fold
magnification) in the frontal area, 2. below average hair
thickness in the frontal area compared to the occiput,
and 3. more than 10% of thin hairs (below 0.03 mm) in
the frontal area. Minor criteria encompass increased
frontal to occipital ratio of: 1. single-hair pilosebaceous
units, 2. vellus hairs, and 3. perifollicular discoloration.
Fulfilment of 2 major criteria or 1 major and 2 minor
criteria allows the diagnosis of FAGA, based on trichos-
copy, with a 98% specificity.
For trichoscopy diagnosis of alopecia areata, evenly
distributed yellow dots (hyperkeratotic plugs) and short
vellus hairs are the most sensitive markers and black dots,
tapering hairs (or micro-exclamation mark hairs), and
broken hairs are the most specific markers [26, 27] (Fig. 1).
There are no specific trichoscopy features of telogen
effluvium; however, this disease may be suspected based
on short, dark regrowing hairs and the presence of hair
follicles in the absence of features of alopecia areata.
Ectodermal dysplasia, which may be associated with
a variety of endocrine abnormalities, may be suspected
based on abnormalities in hair shaft structure and co-
lour, as visualized in trichoscopy.
Light microscopy
Light microscopy may be useful to directly assess the
hair shaft, its anomalies, and thickness. This method is
rarely used but is particularly useful for the evaluation
of genetic hair dystrophies [28].
Figure 1. Trichoscopy is a new technique, which allows non-invasive differentiation of hair disorders.In androgenic alopecia (A,B) most
prominent is hair shaft thickness heterogeneity and presence of vellus hairs. In diffuse alopecia areata (C,D) micro-exlamation mark
hairs and tapered hairs domine in the in the picture and black dots are present. In both diseases multiple yellow dots are visible, what
differentiates these diseases from other causes of hair loss 
Rycina 1. Trichoskopia jest nową techniką pozwalającą na nieinwazyjne różnicowanie łysienia. W łysieniu androgenowym (A, B)
dominuje zmienna grubość włosa i obecność włosów ścieńczałych. W rozlanym łysieniu plackowatym (C, D) na zdjęciu dominują włosy
wykrzyknikowe i zwężające się, obecne są czarne punkty. W obu chorobach widoczne są liczne żółte punkty, co odróżnia je od innych
przyczyn łysienia
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Polarized light microscopy
Polarized light is light in which all the rays oscillate in
one plane. A polarizing microscope has two disk acces-
sories. They are made up of polarizing plastic that allows
light oscillating in one plane to pass. One of them is called
the polarizer (placed below the condenser). Another sim-
ilar disc is placed in the top part of the microscope and
cuts off all the light oscillating in a perpendicular plane.
This disc is called the analyzer. The placement of the discs
is such that they allow light to pass vibrating in planes
perpendicular to each other, which allows the visualiza-
tion of some hair shaft abnormalities.
Polarized light microscopy is of particular value in
trichothiodystrophy, where the characteristic alternate
dark and white bands of hair shaft can be seen. This
sign is known as a ”tiger tail” appearance, which is not
visualized under light microscopic examination [29].
Pathology
Pathology examination of a scalp biopsy is an invasive
technique, but remains a standard in diagnosing hair
loss. The biopsy is usually performed with a 4-mm cy-
lindrical punch. Some pathologists suggest performing
at least 3 biopsies [30]: two from the affected site (one
for vertical and one for horizontal evaluation) and one
from a non-affected site (for horizontal evaluation only).
Clinicians usually prefer to perform one biopsy, and
another only if needed for diagnostic purposes. Increas-
ingly, trichoscopy is used to choose the proper area for
scalp biopsy. Pathology enables evaluation of hair folli-
cle structure, anagen and telogen hairs, hair follicle min-
iaturization, perifollicular infiltrates, and other abnor-
malities in the affected skin.
Immunopathology of hair follicles
Immunopathology of hair follicles may be performed
to visualize selected molecules within the hair follicle
[31, 32]. This method does not appear to be useful for
diagnosing hair loss in endocrine disorders.
Confocal microscopy
Reflectance confocal laser scanning microscopy, also
known as reflectance confocal microscopy (RCM), is an
optical technique that allows non-invasive imaging of
the upper portion of the skin at a resolution that per-
mits visualization of cellular, with near histological res-
olution, details in real time. With a penetration depth
of about 200 micrometres, the technique allows non-
invasive imaging of the epidermis and upper dermis
and distal parts of hair follicles and hairs. The system
generates 500 × 500 micrometre fields of vision from
a total 8 × 8mm area, which may be analyzed in a sin-
gle session. These optical sections may be evaluated in
horizontal blocks, vertical stacks, or “cubes”, giving
a pseudo-3D visualization of analyzed structures [33, 34].
RCM has been used for the assessment of benign and
malignant pigmented lesions, in particular for early diag-
nosis of melanoma. Recent studies showed the potential
application of this method in evaluating patients with hair
loss [35]. It has been shown in case studies that this meth-
od may be of benefit as a supporting tool in diagnosing
alopecia areata, androgenic alopecia, and genetic hair
dystrophies (Fig. 2). The advantage of this method is the
highest possible magnification in non-invasive skin im-
aging. A disadvantage is the small width of the visual-
ized area, and thus the risk of inadequate sampling. New
Figure 2.  Hair shaft of a patient with trichothiodystrophy, which
may be associated with hypogonadism and other developmental
abnormalities, shows no significant abnormalities in  light
microscopy (A),  a characteristic „tiger-tail” stripes in polarized
ligh microscopy (B) and a grainy structure in reflectance confocal
microscopy (C)
Rycina 2. Obrazy fragmentu włosa pacjenta z trichotiodystrofią,
która może towarzyszyć hypogonadyzmowi i innym zaburzeniom
rozwojowym nie wykazuje żadnych zmian w mikroskopie
świetlnym (A), charakterystyczne paski „ogonu tygrysa” w świetle
spolaryzowanym (B) i ziarnista struktura w refleksyjnym
mikroskopie konfokalnym (C)
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RCMs are equipped with a videodermoscope to allow
better selection of the area to be evaluated.
Conclusions
In conclusion, diagnosing hair loss is a complex and
sometimes time-consuming process. However, detailed
hair examination may occasionally lead to the suspicion
of an endocrine disorder. Diagnosing hair loss in patients
with an established diagnosis of an endocrine disorder
is essential to exclude other coexisting causes of hair loss
in clinical practice. Current hair evaluation techniques
allow precise assessment of hair loss and may also serve
as a sensitive parameter in clinical trials. 
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